Skip to main content

On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease.

Ross BM, Knowler JT, McCulloch J

Publication: J Neurochem (1992) • Vol 58 • Page 1810-9PMID: 1560235View on PubMed

Purpose

The purpose of this paper was to examine the effect of post-mortem interval (PMI), presence of Alzheimer's disease, patient age, and brain region on the levels of the G protein subunit (Gs-alpha, G-beta1, and G-beta2) mRNA and 28s ribosomal RNA (rRNA) by northern blot analysis.

Conclusion

No correlation in the relative amount of the G protein subunit mRNA or 28s rRNA were found with patient age, postmortem interval or presence of Alzheimer's disease. The authors found interindividual variation was very high and may account for the lack of observed changes given the relatively small sample sizes. A high degree of correlation within the patient in terms of relative quantities of RNA was observed (Pearson's coefficient of 0.90). Degradation of RNA in the hippocampus, cerebellum, or frontal cortex varied between patients but within a patient degradation levels appeared similar across all three brain regions. The authors conclude that there is a high degree of variability in RNA degradation and expression patterns between individuals, that degradation and expression patterns do not correlate with patient age, PMI or Alzheimer's disease, and may instead be attributable to premortem factors not assessed.

Studies (2)

Purpose

The purpose of this study was to examine the effect of disease state (Alzheimer's disease, control), PMI(3-23 h), and patient age (55-96 y) on the levels of Gs-alpha, G-beta1, and G-beta2 mRNA and 28s rRNA by northern blot analysis.

Summary of Findings

Northern analysis identified two known G-beta subunits and multiple Gs-alpha subunits. No correlation in the relative amount of the G protein subunit mRNA or 28s rRNA were found with patient age, postmortem interval or presence of Alzheimer's disease. Interindividual variation was very large at 44% of average for all mRNAs and disease states. The authors note that given the level of variability at least 40 individuals would be needed to find a correlation versus the 6 used in this study. Quantities of the different mRNAs examined within a patient correlated well, for example Gs-alpha and G-beta2 in the frontal cortex had a Pearson's coefficient of 0.90. The authors conclude that G protein subunit and 28s RNA levels are not impacted by PMI (3-23 h), patient age or the presence of Alzheimer's disease but rather have a high degree of interindividual variability possibly due to premortem factors not assessed in this study.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Autopsy
    Alzheimer's Disease
    Normal
  • Platforms

    RNANorthern blot
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's Disease
    Normal
    PreaquisitionPatient age
    55 y
    69 y
    71 y
    74 y
    76 y
    78 y
    80 y
    83 y
    84 y
    86 y
    88 y
    92 y
    96 y
    PreaquisitionPostmortem interval
    11 h
    12 h
    15 h
    16 h
    17 h
    19 h
    2 h
    3 h
    4 h
    6 h
    7 h
    8 h
    Northern blot SpecificTargeted nucleic acid
    G protein subunit beta 1 (G-beta1)
    G protein subunit beta 2 (G-beta2)
    Subunit alpha of the adenylate cyclase stimulatory protein (Gs-alpha)